Abstract
The protean manifestations of HIV infection derive from its complex dysregulation of the immune system. The spectrum of rheumatological disorders reported in children living with HIV infection include arthralgia, arthritis, myopathies, vasculopathies, systemic lupus erythematosus, diffuse infiltrative lymphocytosis syndrome, and complications of highly active antiretroviral therapy. The advent of highly active antiretroviral therapy has significantly improved the prognosis and changed the profile of rheumatologic disorders. This chapter reviews the pathogenesis, the clinical presentations and the treatment of the rheumatological disorders associated with HIV infection in children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mody G, Parke F, Reveille JD. Articular manifestations of human immunodeficiency virus infection. Best Pract Res Clin Rheumatol. 2003;17(2):265–87.
Njobvu P, McGill P. Human immunodeficiency virus related reactive arthritis in Zambia. J Rheumatol. 2005;32:1299–304.
Berman A, Espinoza LR, Diaz JD, et al. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med. 1988;85:59–64.
Adizie MRJ, Hodkinson B, French N, Adebajo AO. Inflammatory arthritis in HIV positive patients: a practical guide. BMC Infect Dis. 2016;16:100. https://doi.org/10.1186/s12879-016-1389-2.
Chinniah K, Mody GM, Bhimma R, Adhikari M. Arthritis in association with human immunodeficiency virus infection in black African children: causal or coincidental? Rheumatology (Oxford). 2005;44:915–20.
Martinez-Rojano H, Juarez Hernandez E, Ladròn De Guevara G, del Carmen Gorbea-Robles M. Rheumatologic manifestations of paediatric HIV infection. AIDS Patient Care STDS. 2001;15:519–26.
Schuval SJ, Bonagura VR, Ilowite NT. Rheumatologic manifestations of paediatric human immunodeficiency virus infection. J Rheumatol. 1993;20:1578–82.
Chakladar D, Mondal RK, Sabul TK, Bhowmik S, Biswas T. Musculoskeletal manifestations in paediatric patients infected with human immunodeficiency virus: developing country perspective. Eur J Rheumatol. 2018;6(1):7–11. https://doi.org/10.5152/eurjrheum.2018.18045.
Suri D, Sharma A, Bhattad S, Rawat A, Arora S, Minz RW, et al. Arthritis in childhood human immunodeficiency virus infection predominantly associated with human leukocyte antigen B27. Int J Rheum Dis. 2016;19:1018–23.
Zaborowski AG, Parbhoo D, Chinniah K, Visser L. Uveitis in children with human immunodeficiency virus-associated arthritis. J AAPOS. 2008;12:608–10.
Lawson E, Walker-Bone K. The changing spectrum of rheumatic disease in HIV infection. B Med Bull. 2012;103(1):203–21.
McGonagle D, Reade S, Marzo-Ortega H, Gibbon W, O’Connor P, Morgan E, Emery P. Human immunodeficiency virus associated spondyloarthropathy: pathogenic insights based on imaging findings and response to highly active antiretroviral treatment. Ann Rheum Dis. 2001;60:696–8.
Patel N, Patel N, Espinoza LR. HIV infection and rheumatic diseases: the changing spectrum of clinical enigma. Rheum Dis Clin N Am. 2009;35:139–61.
Nguyen BY, Reveille JD. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Curr Opin Rheumatol. 2009;21:404–10.
Fox C, Bone W. Evolving spectrum of HIV-associated rheumatic syndromes. Best Pract Res Clin Rheumatol. 2015;29(2):244–58.
Johnson RW, Williams FM, Kazi S, Dimachkie MM, Reveille JD. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum. 2003;49(2):172–8.
Scruggs ER, Dirks Naylor AJ. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Pharmacology. 2008;82(2):83–8.
Hart AM, Wilson AD, Montovani C, Smith C, Johnson M, Terenghi G, et al. Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS. 2004;18(11):1549–60.
Kenyon C, Pillay K, Heckmann JM. Beware of the “normal” creatine kinase levels in HIV-associated polymyositis: the Groote Schuur experience. S Afr Med J. 2010;100(3):156–7.
Heckmann JM, Pillay K, Hearn AP, Kenyon C. Polymyositis in African HIV infected subjects. Neuromuscul Disord. 2010;20:735–9.
Maganti R, Reveille JD, Williams FM. Therapy insight: the changing spectrum of rheumatic disease in HIV infection. Nat Clin Pract Rheumatol. 2008;4(8):428–38.
Joshi VV, Pawel B, Connor E, Sharer L, Oleske JM, Morrison S, Marin-Garcia J. Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol. 1987;7:261–75.
Patsalides AD, Wood LV, Atac GK, Sandifer E, Butman JA, Patronas NJ. Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings. Am J Roentgenol. 2002;179:999–1003.
Chetty R. Vasculitides associated with HIV infection. J Clin Pathol. 2001;54:275–8.
Schieffelin JS, Williams PL, Djokic D, et al. Central nervous system vasculopathy in HIV-infected children enrolled in the pediatric AIDS Clinical Trials Group 219/219C Study. J Pediatr Infect Dis Soc. 2013;2:50–6.
Demopoulos D, Hendson W, Technau K, Cilliers AM. (2009) vasculopathy in HIV-infected children—a case series. SAfr J Child Health. 2009;3(1):27–30.
Chalom EC, Rezaee F, Mendelson J. Paediatric patient with SLE and congenitally acquired HIV. Peadiatr Rheumatol Online J. 2008;6:7. https://doi.org/10.1186/1546-0096-6-7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chinniah, K. (2020). Rheumatological Manifestations of HIV Infection. In: Bobat, R. (eds) HIV Infection in Children and Adolescents. Springer, Cham. https://doi.org/10.1007/978-3-030-35433-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-35433-6_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35432-9
Online ISBN: 978-3-030-35433-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)